...
首页> 外文期刊>Applied Microbiology and Biotechnology >Characterization of a novel two-component regulatory system involved in the regulation of both actinorhodin and a type I polyketide in Streptomyces coelicolor
【24h】

Characterization of a novel two-component regulatory system involved in the regulation of both actinorhodin and a type I polyketide in Streptomyces coelicolor

机译:新型的两组分调节系统的特征,涉及调节天蓝色链霉菌中的放线菌素和I型聚酮化合物

获取原文
获取原文并翻译 | 示例
           

摘要

To seek more information on function of two component regulatory systems (TCSs) in Streptomyces coelicolor, a dozen TCS-knockout mutants were generated, and phenotype changes were determined. One TCS (SCO5403/5404)-deleted mutant with phenotype change was obtained. Here, we report the characterization of this novel TCS, designated as RapA1/A2 (regulation of both actinorhodin and a type I polyketide), using genetic and proteomic approaches. Although growth and morphological analyses showed no difference between the knockout mutant and wild-type strain M145, a visible decrease of the production of actinorhodin (Act) was observed in rapA1/A2 mutant. The decrease can be restored by introducing rapA1/ A2 genes on an integrative vector. A 2D-gel based proteomic analysis showed that knockout of rapA1/ A2 resulted in reduced expression of a putative 3-oxoacyl-[acyl-carrier protein] reductase that is part of a biosynthetic cluster for a cryptic type I polyketide. Further reverse-transcriptase polymerase chain reaction (RT-PCR) analyses confirmed that expression levels of several biosynthetic genes and the respective pathway-specific regulatory genes actII-ORF4 and kasO for these two clusters were all down-regulated in the rapA1/A2 mutant, compared to M145. Taken together, the results demonstrated that RapA1/A2 may serve as a positive regulator for biosynthesis of both Act and the uncharacterized polyketide in S. coelicolor, and the effects exerted by RapA1/A2 were dependent on the pathway specific regulatory genes.
机译:为了寻找关于在链霉菌中两组分调节系统(TCS)功能的更多信息,生成了12个TCS敲除突变体,并确定了表型变化。获得了一个具有表型变化的TCS(SCO5403 / 5404)缺失的突变体。在这里,我们报告使用遗传和蛋白质组学方法对这种新型TCS的表征,命名为RapA1 / A2(对放线菌丝蛋白和I型聚酮化合物的调节)。尽管生长和形态分析显示敲除突变体和野生型菌株M145之间没有差异,但在rapA1 / A2突变体中观察到放线菌丝蛋白(Act)的产量明显下降。可以通过将rapA1 / A2基因引入整合载体来恢复这种减少。基于2D凝胶的蛋白质组学分析表明,敲除rapA1 / A2导致推定的3-氧代酰基-[酰基载体蛋白]还原酶的表达降低,该酶是I型隐聚酮的生物合成簇的一部分。进一步的逆转录酶聚合酶链反应(RT-PCR)分析证实,在rapA1 / A2突变体中,这两个簇的一些生物合成基因和各自的途径特异性调控基因actII-ORF4和kasO的表达水平均被下调,与M145相比。两者合计,结果表明,RapA1 / A2可以充当Acti和天蓝色链霉菌中未表征的聚酮化合物的生物合成的正调节剂,并且RapA1 / A2发挥的作用取决于途径特异性调节基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号